Cargando…

Anti-Inflammatory Dipeptide, a Metabolite from Ambioba Secretion, Protects Cerebral Ischemia Injury by Blocking Apoptosis Via p-JNK/Bax Pathway

MQ (l-methionyl-l-glutamic acid), anti-inflammatory dipeptide, is one of the metabolites of monocyte locomotion inhibitory factor, a thermostable pentapeptide secreted by Entamoeba histolytica. Monocyte locomotion inhibitory factor injection has been approved as an investigational drug for the poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qian, Dai, Jinwei, Song, Zhibing, Guo, Yuchen, Deng, Shanshan, Yu, Yongsheng, Li, Tiejun, Zhang, Yuefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249563/
https://www.ncbi.nlm.nih.gov/pubmed/34220513
http://dx.doi.org/10.3389/fphar.2021.689007
_version_ 1783716922081148928
author Zhang, Qian
Dai, Jinwei
Song, Zhibing
Guo, Yuchen
Deng, Shanshan
Yu, Yongsheng
Li, Tiejun
Zhang, Yuefan
author_facet Zhang, Qian
Dai, Jinwei
Song, Zhibing
Guo, Yuchen
Deng, Shanshan
Yu, Yongsheng
Li, Tiejun
Zhang, Yuefan
author_sort Zhang, Qian
collection PubMed
description MQ (l-methionyl-l-glutamic acid), anti-inflammatory dipeptide, is one of the metabolites of monocyte locomotion inhibitory factor, a thermostable pentapeptide secreted by Entamoeba histolytica. Monocyte locomotion inhibitory factor injection has been approved as an investigational drug for the potential neural protection in acute ischemic stroke. This study further investigated the neuroprotective effect of MQ in ischemic brain damage. Ischemia-reperfusion injury of the brain was induced in the rat model by middle cerebral artery occlusion. 2,3,5-triphenyltetrazolium chloride staining assay was used to measure cerebral infarction areas in rats. Laser Doppler measurement instrument was used to detect blood flow changes in the rat model. Nissl staining and NeuN staining were utilized to observe the numbers and structures of neuron cells, and the pathological changes in the brain tissues were examined by hematoxylin–eosin staining. Terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick end labeling (TUNEL) staining was used to assess cell apoptosis. The changes in oxidative stress indexes, superoxide dismutase and malondialdehyde (MDA), were measured in serum. Methyl thiazolyl tetrazolium was used to measure the survival rates of PC12 cells. Flow cytometry assessed the apoptosis rates and the levels of reactive oxygen species. Real-time PCR was used to evaluate the mRNA expression levels, and Western blotting was used to analyze the changes in protein levels of p-JNK, Bax, cleaved Caspase3. We revealed that MQ improved neurobehavior, decreased cerebral infarction areas, altered blood flow volume, and the morphology of the cortex and hippocampus. On the other hand, it decreased the apoptosis of cortical neurons and the levels of MDA, and increased the levels of superoxide dismutase. In vitro studies demonstrated that MQ enhanced the cell survival rates and decreased the levels of reactive oxygen species. Compared to the oxygen-glucose deprivation/reperfusion group, the protein and mRNA expressions of p-JNK, Bax, cleaved Caspase3 was decreased significantly. These findings suggested that MQ exerts a neuroprotective effect in cerebral ischemia by blocking apoptosis via the p-JNK/Bax pathway.
format Online
Article
Text
id pubmed-8249563
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82495632021-07-03 Anti-Inflammatory Dipeptide, a Metabolite from Ambioba Secretion, Protects Cerebral Ischemia Injury by Blocking Apoptosis Via p-JNK/Bax Pathway Zhang, Qian Dai, Jinwei Song, Zhibing Guo, Yuchen Deng, Shanshan Yu, Yongsheng Li, Tiejun Zhang, Yuefan Front Pharmacol Pharmacology MQ (l-methionyl-l-glutamic acid), anti-inflammatory dipeptide, is one of the metabolites of monocyte locomotion inhibitory factor, a thermostable pentapeptide secreted by Entamoeba histolytica. Monocyte locomotion inhibitory factor injection has been approved as an investigational drug for the potential neural protection in acute ischemic stroke. This study further investigated the neuroprotective effect of MQ in ischemic brain damage. Ischemia-reperfusion injury of the brain was induced in the rat model by middle cerebral artery occlusion. 2,3,5-triphenyltetrazolium chloride staining assay was used to measure cerebral infarction areas in rats. Laser Doppler measurement instrument was used to detect blood flow changes in the rat model. Nissl staining and NeuN staining were utilized to observe the numbers and structures of neuron cells, and the pathological changes in the brain tissues were examined by hematoxylin–eosin staining. Terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick end labeling (TUNEL) staining was used to assess cell apoptosis. The changes in oxidative stress indexes, superoxide dismutase and malondialdehyde (MDA), were measured in serum. Methyl thiazolyl tetrazolium was used to measure the survival rates of PC12 cells. Flow cytometry assessed the apoptosis rates and the levels of reactive oxygen species. Real-time PCR was used to evaluate the mRNA expression levels, and Western blotting was used to analyze the changes in protein levels of p-JNK, Bax, cleaved Caspase3. We revealed that MQ improved neurobehavior, decreased cerebral infarction areas, altered blood flow volume, and the morphology of the cortex and hippocampus. On the other hand, it decreased the apoptosis of cortical neurons and the levels of MDA, and increased the levels of superoxide dismutase. In vitro studies demonstrated that MQ enhanced the cell survival rates and decreased the levels of reactive oxygen species. Compared to the oxygen-glucose deprivation/reperfusion group, the protein and mRNA expressions of p-JNK, Bax, cleaved Caspase3 was decreased significantly. These findings suggested that MQ exerts a neuroprotective effect in cerebral ischemia by blocking apoptosis via the p-JNK/Bax pathway. Frontiers Media S.A. 2021-06-18 /pmc/articles/PMC8249563/ /pubmed/34220513 http://dx.doi.org/10.3389/fphar.2021.689007 Text en Copyright © 2021 Zhang, Dai, Song, Guo, Deng, Yu, Li and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zhang, Qian
Dai, Jinwei
Song, Zhibing
Guo, Yuchen
Deng, Shanshan
Yu, Yongsheng
Li, Tiejun
Zhang, Yuefan
Anti-Inflammatory Dipeptide, a Metabolite from Ambioba Secretion, Protects Cerebral Ischemia Injury by Blocking Apoptosis Via p-JNK/Bax Pathway
title Anti-Inflammatory Dipeptide, a Metabolite from Ambioba Secretion, Protects Cerebral Ischemia Injury by Blocking Apoptosis Via p-JNK/Bax Pathway
title_full Anti-Inflammatory Dipeptide, a Metabolite from Ambioba Secretion, Protects Cerebral Ischemia Injury by Blocking Apoptosis Via p-JNK/Bax Pathway
title_fullStr Anti-Inflammatory Dipeptide, a Metabolite from Ambioba Secretion, Protects Cerebral Ischemia Injury by Blocking Apoptosis Via p-JNK/Bax Pathway
title_full_unstemmed Anti-Inflammatory Dipeptide, a Metabolite from Ambioba Secretion, Protects Cerebral Ischemia Injury by Blocking Apoptosis Via p-JNK/Bax Pathway
title_short Anti-Inflammatory Dipeptide, a Metabolite from Ambioba Secretion, Protects Cerebral Ischemia Injury by Blocking Apoptosis Via p-JNK/Bax Pathway
title_sort anti-inflammatory dipeptide, a metabolite from ambioba secretion, protects cerebral ischemia injury by blocking apoptosis via p-jnk/bax pathway
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249563/
https://www.ncbi.nlm.nih.gov/pubmed/34220513
http://dx.doi.org/10.3389/fphar.2021.689007
work_keys_str_mv AT zhangqian antiinflammatorydipeptideametabolitefromambiobasecretionprotectscerebralischemiainjurybyblockingapoptosisviapjnkbaxpathway
AT daijinwei antiinflammatorydipeptideametabolitefromambiobasecretionprotectscerebralischemiainjurybyblockingapoptosisviapjnkbaxpathway
AT songzhibing antiinflammatorydipeptideametabolitefromambiobasecretionprotectscerebralischemiainjurybyblockingapoptosisviapjnkbaxpathway
AT guoyuchen antiinflammatorydipeptideametabolitefromambiobasecretionprotectscerebralischemiainjurybyblockingapoptosisviapjnkbaxpathway
AT dengshanshan antiinflammatorydipeptideametabolitefromambiobasecretionprotectscerebralischemiainjurybyblockingapoptosisviapjnkbaxpathway
AT yuyongsheng antiinflammatorydipeptideametabolitefromambiobasecretionprotectscerebralischemiainjurybyblockingapoptosisviapjnkbaxpathway
AT litiejun antiinflammatorydipeptideametabolitefromambiobasecretionprotectscerebralischemiainjurybyblockingapoptosisviapjnkbaxpathway
AT zhangyuefan antiinflammatorydipeptideametabolitefromambiobasecretionprotectscerebralischemiainjurybyblockingapoptosisviapjnkbaxpathway